Pharmaceutical Technology

MARCH 16, 2023

Dr. Barry DeCoster, PhD, an associate professor of bioethics at the University of Michigan, describes gender affirming care as “safe and effective” for most patients. Campo-Engelstein is the director of the Institute for Bioethics & Health Humanities at the University of Texas Medical Branch, Galveston.

Labelling 144

Labelling Bioethics Pharmaceutical Companies Pharmaceutical Companies 144

Putting Patients First Blog

NOVEMBER 14, 2023

According to a 2021 study, patients with multiple chronic conditions often face complex medical decisions, and their experiences with the health care system can significantly impact the outcomes.29 Medical futility and disability bias: part of the bioethics and disability series. Chronic pain among adults – United States, 2019-2021.

Communication 40

Communication Hospitals Bioethics Documentation 40

STAT

MARCH 6, 2023

”It’s imprudent and unwise and not the way forward, even for people who are very ill,” said Dr. Arthur Caplan, a professor of bioethics at the NYU Langone hospital system in New York who chaired a university panel that studied the FDA’s compassionate use program. Her husband said he had no regrets.

Vaccines 246

Vaccines Bioethics Immunity Immunization 246